PrashantKumar Khirsariya, Ph.D., M.Sc.
Researcher II, Department of Chemistry
Total number of publications: 29
2023
-
4-(1H-IMIDAZOL-5-YL)-1H-PYRROLO [2,3-B] PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS
Publisher: China National Intellectual Property Administration, state: China, patent's number: CN111936496, year: 2023
-
Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity
Angewandte Chemie International Edition, year: 2023, volume: 62, edition: 11, DOI
2022
-
4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: Canadian Intellectual Property Office, state: Canada, patent's number: CA3085967, year: 2022
-
4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: European Patent Office, state: Germany, patent's number: EP3774795, year: 2022
-
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11498920, year: 2022
-
Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides
Journal of Medicinal Chemistry, year: 2022, volume: 65, edition: 7, DOI
-
백혈병, 림프종 및 고형 종양의 치료에 사용하기 위한 4-(1H-이미다졸-5-일)-1H-피롤로[2,3-b]피리딘
Publisher: Korean Intellectual Property Office, state: Korea, Republic of, patent's number: KR10-2465111, year: 2022
-
白血病、リンパ腫および固形腫瘍の治療に使用するための4-(1H-イミダゾール-5-イル)-1H-ピロロ[2,3-b]ピリジン
Publisher: Japan Patent Office, state: Japan, patent's number: JP7008967, year: 2022
2021
-
4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: The Australian Patents Register, state: Australia, patent's number: AU 2019246220, year: 2021
-
Cytoprotective activities of kinetin purine isosteres
Bioorganic and Medicinal Chemistry, year: 2021, volume: 33, edition: March, DOI